ARS Pharmaceuticals to Host Virtual neffy® Investor Day on March 7, 2024

SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients from severe allergic reactions that could lead to anaphylaxis, today announced that it will host a…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks